Tradestie Institutional Equity Comparison Engine

ALDX vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, ALDX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, ALDX sits in BREAKDOWN (29th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
ALDX N/M vs CRMD 49.0x Fwd P/E
Growth & Margin Winner CRMD
Op Margin 0.0% vs 41.0% ยท YoY +0.0% vs -47.7%
Momentum & Technical Winner CRMD
1Y -86.7% vs -56.2% ยท 52W Pos 3% vs 3%
Options & Structure Winner Tie
BREAKDOWN (29th %ile IV) vs BREAKDOWN (25th %ile IV)
ALDX NASDAQ
Aldeyra Therapeutics, Inc.
Pharmaceutical Preparations
$0.67
+4.02% 1D
Market Cap $38.2M
1M Return -4.34%
1Y Return -86.66%
Forward P/E N/M
Unified AI Score
41.6 / 100 SELL
Tech 40.0 Fund 55.0 Flow 69.0 Mom 58.9
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ALDX -86.66% CRMD -56.16% Spread: +30.5 pp (CRMD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ALDX TTM Op. Margin: 0.0% CRMD TTM Op. Margin: 41.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ALDX vs CRMD. Trailing 12-month operating profitability (ALDX 0.0% vs CRMD 41.0%) and valuation multiples (ALDX N/M vs CRMD 49.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ALDX (2) vs CRMD (8)
Institutional Metric ALDX CRMD Criterion Row Winner
Market Capitalization Scale $38.2M $384.7M Larger Scale CRMD
Trailing P/E Ratio Valuation N/M 2.4x Lower Multiple CRMD
Forward P/E Ratio Valuation N/M 49.0x Lower Multiple CRMD
Revenue Growth (YoY) Growth +0.0% -47.7% Higher Growth ALDX
Operating Margin (TTM) Profitability 0.0% 41.0% Higher Margin CRMD
Net Profit Margin Profitability 0.0% 15.5% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency -45.3% 15.3% Higher ROE CRMD
52-Week Range Position Momentum 3% ($1โ€“$6) 3% ($5โ€“$13) Stronger Trend CRMD
Beta / 30D Volatility Risk Regime 1.12ฮฒ ยท 89% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk ALDX
Unified Institutional Score Composite Signal 41.6 / 100 (SELL) 53.2 / 100 (HOLD) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ALDX vs CRMD Buy Guide
ALDX BREAKDOWN
165d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 29th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ALDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ALDX nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.